News
President Trump crashed a Mother’s Day “celebration” alongside former Fox News host Jeanine Pirro and Defense Secretary Pete Hegseth during this week’s “Saturday Night Live” cold open.
Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.
These cold lunch ideas are perfect for bringing to the office to enjoy during your lunch break. Ready in just 20 minutes or less, these lunches will keep you cool and satisfied for the remainder ...
safety and initial efficacy of enteric-coated tablets of ANX1502 in up to seven patients with cold agglutinin disease (CAD). Next Milestone: POC trial completion in up to seven CAD patients ...
Despite playing below expectations, he hadn't had back-to-back games without a hit all season before this cold spell. His batting average has dropped from an already uninspiring .245 to an anemic ...
Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
Another New Brunswick business owner testified in Daniel Bard's trial about providing his firm thousands of dollars on the promise of millions in financing, and then facing financial trouble when ...
and cold agglutinin disease (CAD), with slightly earlier programmes in haematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) and amyotrophic lateral sclerosis ...
Traveling in cold weather conditions can be life threatening. The information provided here is designed for educational use only and is not a substitute for specific training or experience. Princeton ...
To prevent the spread of illness, the Centers for Disease Control and Prevention (CDC) recommend washing your hands in these situations: Your teeth are a window into your health, and your mouth is ...
The rare autoimmune disease is characterized by rapidly progressing and severe weakness that can lead to complete paralysis, often requiring intensive care and mechanical ventilation. Tanruprubart ...
This adjustment follows an evaluation of Annexon’s ongoing open-label, single-arm proof of concept study for ANX1502, aimed at treating cold agglutinin disease. The study is expected to yield results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results